BioSpace News Archive

-- Company Will Provide a KEYNOTE-695 Update, an Overview of its Registrational-Enabled Cervical Cancer Study and Key 2019 Milestones

Lemborexant taken at bedtime had no significant effect on automobile driving performance the next morning in healthy adult and elderly volunteers

NationsHearing, LLC., a leader in the hearing healthcare industry, today announced their customer relationship management (CRM) application and the underlying supporting infrastructure has earned Certified status for information security by HITRUST.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2018 after the U.S. markets close on February 6, 2019.

The Mesothelioma Victims Center is urging a family dealing with an ‘out of the blue’ mesothelioma diagnosis involving a loved one or family member to call them anytime at 800-714-0303 about secondhand exposure to asbestos and mesothelioma and for direct access to Mr. Erik Karst - founding partner of Karst von Oiste, one of the nation premier mesothelioma and asbestos exposure lung cancer law firms.

A stellar cast of experts offered a master class of thought leadership and innovation for the prevention and treatment of cardiovascular disease in low resource settings.

BioIQ’s new white paper examines what is at stake for health plans and members when it comes to closing care gaps and what it takes to execute a successful gap closure program.

– Collaboration Aims to Expand the Use of Bone Marrow Transplant to Treat Hematologic Malignancies and Serious Blood Disorders

As the Number of Analytical Monitoring Tests for Biopharmaceuticals Skyrockets, Waters Builds Intelligence into a Fit-for-Purpose System

DionyMed Enters Massachusetts Market with Award-Winning Brands